Over-the-counter drug · UNAPPROVED DRUG OTHER
Obagi Nu-Derm System Normal-Dry Skin Transformation Trial NDC 62032-913
hydroquinone, homosalate, octisalate, zinc oxide · Kit · Obagi Cosmeceuticals LLC
NDC codes
FDA NDC DirectoryProduct NDC (as listed)62032-913Labeler and product segments. Claims need a package NDC.
Product NDC at billing width62032-0913Add the package segment from the table below.
Product information
- Brand name (proprietary)
- Obagi Nu-Derm System Normal-Dry Skin Transformation Trial
- Generic name (nonproprietary)
- hydroquinone, homosalate, octisalate, zinc oxide
- Dosage form
- Kit
- Labeler
- Obagi Cosmeceuticals LLC
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 62032-913_f1292c32-db82-4875-b681-b984c56f9cffSPL ID f1292c32-db82-4875-b681-b984c56f9cffSPL set ID e2c23345-69df-47a1-8e6b-b6225080d363RxCUI 197795
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses helps prevent sunburn If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Excerpt only. Read the full label for complete information.